AVEX (AEVEX Corp.)
Insider Trading Activity
Every open-market purchase and sale reported by AVEX officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-08 | Brian Raduenz | Director | D | — | — |
| 2026-06-08 | MADISON DEARBORN PARTNERS LLC | 10%+ Owner | MIXED | — | — |
| 2026-05-14 | Michael Andrew Jackson | See Remarks | A | — | — |
| 2026-05-14 | Charles Roger Wells IV | Chief Executive Officer | A | — | — |
| 2026-05-14 | BRADLEY H FELDMANN | Director | A | — | — |
| 2026-05-14 | Todd Booth | Chief Financial Officer | A | — | — |
| 2026-05-14 | Matthew Klein | Director | A | — | — |
| 2026-05-14 | Christine M. Morrison | Chief Legal Officer | A | — | — |
| 2026-05-14 | Benjamin Spacapan | Director | A | — | — |
| 2026-05-14 | Brett P Hush | See Remarks | A | — | — |
| 2026-05-14 | MATTHEW W NORTON | Director | A | — | — |
| 2026-05-14 | Brandon Levitan | Director | A | — | — |
| 2026-05-14 | Brian Raduenz | Director | A | — | — |
| 2026-04-21 | Todd Booth | Chief Financial Officer | Buy | — | — |
| 2026-04-21 | Charles Roger Wells IV | Chief Executive Officer | — | — | — |
| 2026-04-20 | Michael Andrew Jackson | See Remarks | Buy | — | — |
| 2026-04-20 | Brian Raduenz | Director | Buy | — | — |
| 2026-04-20 | Charles Roger Wells IV | Chief Executive Officer | Buy | — | — |
| 2026-04-20 | Brett P Hush | See Remarks | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 22,858,846 | — |
| — | Director | 958,876 | — |
| — | Chief Executive Officer | 94,000 | — |
| — | See Remarks | 42,320 | — |
| — | Chief Financial Officer | 42,220 | — |
| — | Chief Legal Officer | 28,204 | — |
| — | See Remarks | 20,410 | — |
| — | Director | 8,250 | — |
| — | Director | 8,250 | — |
| — | Director | 8,250 | — |
| — | Director | 8,250 | — |
| — | Director | 8,250 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the AVEX quote page; the site-wide leaderboard is on the insider transactions hub.